Mirabella 0,10+0,02 mg filmovertrukne tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

mirabella 0,10+0,02 mg filmovertrukne tabletter

exeltis healthcare s.l - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg

Mirabella 28 0,10+0,02 mg filmovertrukne tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

mirabella 28 0,10+0,02 mg filmovertrukne tabletter

exeltis healthcare s.l - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg

Rigevidon 0,15+0,03 mg overtrukne tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

rigevidon 0,15+0,03 mg overtrukne tabletter

gedeon richter plc. - ethinylestradiol, levonorgestrel - overtrukne tabletter - 0,15+0,03 mg

Vellena 75+20 mikrogram overtrukne tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

vellena 75+20 mikrogram overtrukne tabletter

actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+20 mikrogram

Vellena 75+30 mikrogram overtrukne tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

vellena 75+30 mikrogram overtrukne tabletter

actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram

Denise 150+30 mikrogram tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

denise 150+30 mikrogram tabletter

2care4 aps - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram

Alunbrig Evropska unija - danščina - EMA (European Medicines Agency)

alunbrig

takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

Copiktra Evropska unija - danščina - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.